Scarica l'app Stockscreener
3.02
0.67%
0.02
Precedente Chiudi:
$3.00
Aprire:
$3.01
Volume 24 ore:
79,481
Relative Volume:
2.74
Capitalizzazione di mercato:
$9.69M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.4112
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+0.00%
1M Prestazione:
+0.80%
6M Prestazione:
+12.69%
1 anno Prestazione:
-7.93%
Intervallo 1D:
$2.90
$3.14
Intervallo di 1 settimana:
$2.90
$3.70
Portata 52W:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Nome
Cyclerion Therapeutics Inc
Settore
Industria
Telefono
617-621-7722
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Confronta CYCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
3.02 | 10.68M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-10-20 | Iniziato | Truist | Buy |
| 2021-09-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Iniziato | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie
How Cyclerion Therapeutics Inc. stock reacts to Fed policy changesExceptional ROI - jammulinksnews.com
What drives Cyclerion Therapeutics Inc. stock priceStrong return on assets - Autocar Professional
Diana Tea Company Limited (530959) Signs Major DealFree Consultation - jammulinksnews.com
Cyclerion Therapeutics Inc. Stock Analysis and ForecastExceptional profit potential - Autocar Professional
Is Cyclerion Therapeutics Inc. a good long term investmentMarket-crushing stock picks - jammulinksnews.com
What drives NPWR.WS stock priceAccelerated earnings growth - jammulinksnews.com
HDLB Stock Analysis and ForecastPhenomenal capital appreciation - jammulinksnews.com
Robin Energy Ltd. Stock Analysis and ForecastRapid growth opportunities - Autocar Professional
What analysts say about Cyclerion Therapeutics Inc. stockRapid return acceleration - Autocar Professional
HSPO Stock Analysis and ForecastFree Consultation - jammulinksnews.com
What analysts say about ADIL stockDynamic capital growth - jammulinksnews.com
Is GTSG a good long term investmentFree Wealth Planning Blueprint - jammulinksnews.com
ENTO Stock Analysis and ForecastUnprecedented profits - jammulinksnews.com
Is Columbus McKinnon Corporation a good long term investmentConsistent triple returns - jammulinksnews.com
Is DBVT a good long term investmentUnprecedented profits - jammulinksnews.com
How Cyclerion Therapeutics Inc. stock performs during market volatilityGrowth Stock Monitor - beatles.ru
Cyclerion Therapeutics (NASDAQ:CYCN) Trading Down 3.6% – Time to Sell? - Defense World
Why Cyclerion Therapeutics Inc. stock attracts strong analyst attentionVerified Return Tips - Newser
FIB(fib)Low Risk Stock Strategies - Newser
What makes Cyclerion Therapeutics Inc. stock price move sharplySmart Return Focused Trading - Newser
What makes PotlatchDeltic Corporation stock price move sharplyFree Access to Investment Community - Newser
How United Parcel Service Inc. stock performs during market volatilityFree VIP Group - Newser
What makes Sight Sciences Inc. stock price move sharply2x Return Forecast - Newser
Cyclerion Therapeutics (NASDAQ:CYCN) Stock Price Down 2.4% – Here’s Why - Defense World
Cyclerion Therapeutics Gains Shareholder Support at Annual Meeting - TipRanks
Cyclerion Therapeutics (NASDAQ:CYCN) Trading 6.5% Higher – Time to Buy? - Defense World
Regina Graul, Ph.D., Promoted to Chief Executive Officer - marketscreener.com
Wave Life Sciences Announces Appointment of Dr. Christopher Wright as Chief Medical Officer - GlobeNewswire
Renaissance Technologies LLC Invests $34,000 in Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) - Defense World
Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):